Cannell Capital - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 22 filers reported holding PSYCHEMEDICS CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cannell Capital ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$296,932
-12.9%
74,7940.0%0.07%
+1.5%
Q2 2023$341,061
-13.1%
74,7940.0%0.07%
-10.5%
Q1 2023$392,668
+7.0%
74,7940.0%0.08%
+2.7%
Q4 2022$366,842
-36.2%
74,794
-16.2%
0.07%
-43.9%
Q3 2022$575,000
+1.6%
89,2110.0%0.13%
+15.8%
Q2 2022$566,000
+4.8%
89,211
+13.9%
0.11%
+39.0%
Q1 2022$540,000
+8.4%
78,306
+10.3%
0.08%
+3.8%
Q4 2021$498,00071,0000.08%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 285,903$5,878,0005.05%
Moors & Cabot, Inc. 373,296$7,670,0001.02%
Gs Investments, Inc. 15,500$318,680,0000.24%
QUANTUM CAPITAL MANAGEMENT 47,205$971,0000.23%
North Star Investment Management Corp. 81,150$1,668,0000.20%
RBF Capital, LLC 78,495$1,614,0000.18%
Uniplan Investment Counsel, Inc. 196,882$4,047,0000.16%
CRAWFORD INVESTMENT COUNSEL INC 230,685$4,743,0000.15%
Granite Investment Partners, LLC 67,501$1,388,0000.09%
Municipal Employees' Retirement System of Michigan 58,900$1,211,0000.06%
View complete list of PSYCHEMEDICS CORP shareholders